← back to search

Weiyang Li

Nanjing University of Chinese Medicine · CN
Area of research
Hematology · Epidemiology
Research interest
Research interests include Hepatitis B Virus Studies, Hematopoietic Stem Cell Transplantation, Acute Myeloid Leukemia Research, and Reconstructive Surgery and Microvascular Techniques.
h-index
23
citations
2,342
works
111
NIH funding
primary concept
Medicine
email

Recent publications

Leritrelvir for the treatment of mild or moderate COVID-19 without co-administered ritonavir: a multicentre randomised, double-blind, placebo-controlled phase 3 trial
EClinicalMedicine 2023cited by 43position: middledoi
Three novel structural variations at the major histocompatibility complex and <i>IL12B</i> predispose to psoriasis*
British Journal of Dermatology 2021cited by 9position: middledoi
The correlation of copy number variations with longevity in a genome-wide association study of Han Chinese
Aging 2018cited by 31position: middledoi
A novel block at chromosome 12q24.1 is associated with coronary artery disease in Han Chinese populations
Pharmacogenetics and Genomics 2016cited by 2position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Xiao-Li Tian · Harbin Medical University1 papers (2016–2016)Chun Song · Harbin Medical University1 papers (2016–2016)Han Yan · Harbin Medical University1 papers (2016–2016)Chong Wu · Tulane University1 papers (2016–2016)Jun Cai · Dalian University of Technology1 papers (2016–2016)Li Yang · Sansure Biotech (China)1 papers (2016–2016)Feng Jiang · Nantong University1 papers (2016–2016)Gu-Yan Zheng · Harbin Medical University1 papers (2016–2016)Bin Zhao · Central South University1 papers (2016–2016)Jie Dong · King University1 papers (2016–2016)Lijuan Jin · Harbin Medical University1 papers (2016–2016)Xueqi Li · Sun Yat-sen University Cancer Center1 papers (2016–2016)Xinchun Yang · Harbin Medical University1 papers (2016–2016)